Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)

[1]  V. Thiel.  Wirkmechanismus bei Blutkrebs entdeckt , 2017, TumorDiagnostik & Therapie.

[2]  L. Bullinger,et al.  Heterodimerization of AML1/ETO with CBFβ is required for leukemogenesis but not for myeloproliferation , 2017, Leukemia.

[3]  L. Bullinger,et al.  Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group , 2017, Leukemia.

[4]  Heather L. Mulder,et al.  The genomic landscape of core-binding factor acute myeloid leukemias , 2016, Nature Genetics.

[5]  L. Bullinger,et al.  Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG). , 2013, Blood.

[6]  K. Döhner,et al.  Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Ming Yan,et al.  Persistent altered fusion transcript splicing identifies RUNX1‐RUNX1T1+ AML patients likely to relapse , 2010, European journal of haematology.

[8]  Y. Liang,et al.  AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2 , 2009, Leukemia.

[9]  Axel Benner,et al.  Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. , 2008, The New England journal of medicine.

[10]  Ming Yan,et al.  RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis. , 2006, Blood.

[11]  Ming Yan,et al.  A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis , 2006, Nature Medicine.

[12]  W. Hiddemann,et al.  The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. , 2005, The Journal of clinical investigation.

[13]  J. Downing,et al.  Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. , 2002, Cancer cell.

[14]  M. Procházka,et al.  Structure and expression of the human MTG8/ETO gene. , 1998, Gene.